At present, common thyroid hormone detection methods include Chemiluminescent Immunoassay (CLIA) and Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry (ID-LC /MS /MS). The accuracy of the LC-MS/MS results is clinically recognized, but why is CLIA still the most preferred method for thyroid hormone detection?

The difficulty of the application of LC-MS/MS in clinical thyroid hormones detection mainly lies in the fT3/fT4 detection, in which, the separation of fT3/fT4 needs to ensure the endogenous balance between the bound state and the free state. Current LC-MS/MS separation system takes a processing time of 30 min-24h, which is very time-consuming. Moreover, it is a challenge to avoid non-specific binding of the sample to the surface of the membrane or device during the separation process.

In conclusion, the complex and time-consuming sample pre-processing for LC-MS/MS, the unavoidable non-specific binding on the membrane surface, and the demands for automation in clinics have made the popularization of LC-MS/MS in clinical testing particularly difficult.

T3/T4 Sandwich Antibody

High Sensitivity · One Step Assay · ICA/CLIA Verified

The binding sites of small molecule compounds such as T3 and T4 and the corresponding antibodies are mostly in a cave structure, and most of their structure is covered, resulting in insufficient space for antibody binding. Therefore, traditional Sandwich Immunoassay technology is difficult to detect small molecules, and most of the T3/T4 detection kits use Competitive Immunoassay. With years of experience in developing small molecule sandwich antibodies, OkayBio has successfully developed T3 and T4 sandwich antibodies.

OkayBio T3 sandwich antibody enables the CLIA detection to realize the upgrade from two-step Competitive Immunoassay to One-step Sandwich Immunoassay, which reduces 50% of the consuming time for thyroid function tests. It is a tremendous breakthrough for multi-projects combined thyroid function tests and POCT rapid tests.

Advantage of Sandwich Immunoassay

advantage
Difference in signal: Sandwich VS Competitive

Figure 1. Difference in signal: Sandwich VS Competitive

Work flow in CLIA Sandwich VS Competitive

Figure 2. Work flow in Chemiluminescent immunoassay (CLIA) Sandwich VS Competitive: The Sandwich Immunoassay facilitates a streamlined "One-step assay" approach, wherein the capture monoclonal antibody (mAb), detection mAb, and the sample can be mixed or incubated simultaneously. This innovative process results in a significant time-saving of 50% compared to the traditional Competitive Immunoassay, where separate incubation and washing steps are mandatory for the antibody-antigen interaction.

T3 Monoclonal Antibody

Product Performance

T3 sandwich antibody pair (R515n5-R514n5) has been verified with its signal-to-noise ratio (S/N) on the direct Chemiluminescent Immunoassay (CLIA) platform is 10 times that of the Competitive Immunoassay. The sensitivity of fT3 detection is ≥0.1pmol/L, and the correlation between the detection results and Roche assigned samples was R² >0.99 on Chemiluminescent Immunoassay (CLIA) and the correlation of T3 sandwich antibody pair (R513c8, R515n5) was R² >0.94 on Time-resolved Fluorescent Immunoassay (TRFIA).

Chemiluminescent Immunoassay (CLIA) platform

Roche assigned fT3/tT3 clinical samples were tested via the R515n5 (Capture)- R514n5 (Detection) pair on direct Chemiluminescent Immunoassay (CLIA) platform.

fT3 Lowest Detection Limit
Direct Chemiluminescent Immunoassay (CLIA)

Calibrator	Concentration（pmol/L）	RLU avg. (20 times)	Curve
S1	0	5549	y=38133x+5407
S2	3.3	131246
SD		143.2
Lowest Detection Limit (pmol/L)		0.011

fT3 Sample Coincidence Rate
Direct Chemiluminescent Immunoassay (CLIA)

Sample	Concentration (pmol/L)	RLU
1	0.000	5407
2	3.32	131246
3	7.15	265489
4	18.63	856983
5	30.12	1656988
6	49.55	2556942

Table 1. fT3 Clinical comparison analysis data on CLIA

Figure 3. fT3 Standard curve on CLIA

tT3 Sample Coincidence Rate
Direct Chemiluminescent Immunoassay (CLIA)

序號	濃度值（nmol/L）	RLU
1	0.000	3407
2	0.40	90705
3	1.00	244456
4	2.48	1094240
5	4.94	3139387
6	10.12	7028859

Table 2. tT3 Clinical comparison analysis data on CLIA

Figure 4. tT3 Standard curve on CLIA

Cross Reactivity
Direct Chemiluminescent Immunoassay (CLIA)

L-T4 at 500ng/mL was measured via T4 sandwich antibodies (R515n5, R514n5), and the cross-reactivity was 0.01%.

Time-resolved Fluorescent Immunoassay (TRFIA) platform

Roche assigned fT3/tT3 clinical samples were tested via the R513c8 (Capture) - R515n5 (Detection) antibody pair on Time-resolved Fluorescent Immunoassay (TRFIA) platform.

f/tT3 Sample Coincidence Rate
Time-resolved Fluorescent Immunoassay (TRFIA)

Figure 5. fT3 Standard curve on TRFIA

Figure 6. tT3 Standard curve on TRFIA

Concentration (ng/mL)	T value	C value	T/C
0	205	20862	0.0098
0.08	5411	20484	0.2641
0.16	10342	21160	0.4888
0.8	40969	19130	2.1416
4	64041	19371	3.3061
20	84362	21193	3.9807

Table 3. fT3 Clinical comparison analysis data on TRFIA

Concentration (ng/mL)	T value	C value	T/C
5	345	22103	0.0156
20	1564	20159	0.0776
100	8298	18947	0.4380
500	31267	21537	1.4518
2000	50473	20476	2.4650

Table 4. tT3 Clinical comparison analysis data on TRFIA

T4 Monoclonal Antibody

Related Products

Product Name	Catalog#	Recommend Pair	Platform
T3 Antibody	R515n5	R515n5(Capture)-R514n5(Detection) R515n5(Capture)-R513c8(Detection)	CLIA
	R514n5
	R513c8	R513c8(Capture)-R515n5(Detection)	ICA
T4 Antibody	R533c3	R533c3(Capture)-R555a5(Detection)	CLIA
	R534a7	R555a5(Capture)-R533c3(Detection) R555a5(Capture)-R534a7(Detection)	ICA
	R555a5

Sample	Concentration (pmol/L)	RLU
1	0.000	3384
2	4.63	225668
3	11.38	516982
4	19.25	865801
5	52.25	2376942
6	102.50	4750644

Sample	Concentration (pmol/L)	RLU
1	0.000	3055
2	20.86	229219
3	41.65	422718
4	85.96	893682
5	120.12	1233027
6	302.40	3039924